CD6 and myeloid sarcoma: For instance, CD6 has been identified and validated as a risk gene for MS (25), single-nucleotide polymorphisms (rs17824933, rs11230563 and rs12360861) are associated with severe forms of psoriasis (33), and high expression of CD6 has been observed in RA joints (20, 34).